JPMORGAN CHASE & CO

Position in NNVC — Nanoviricides, Inc.

CIK 19617 NEW YORK, NY

Position in NNVC

as of Mar 31, 2026 · filed May 13, 2026 Compact

Position Value

$2,730

-$660 QoQ

Shares Held

3,000

0.0% QoQ

Ownership

0.014%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2020

10 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

JPMORGAN CHASE & CO holds $16,579,226,864 across 407 Biotechnology names. NNVC ranks #317 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	INSM	INSMED Inc	24,150,499	$3,949,089,591
2	REGN	Regeneron Pharmaceuticals, Inc.	4,311,806	$3,331,473,778
3	VRTX	Vertex Pharmaceuticals Inc / Ma	7,033,156	$3,140,585,469
4	ALNY	Alnylam Pharmaceuticals, Inc.	6,323,752	$2,092,339,815
5	NUVL	Nuvalent, Inc.	3,088,349	$316,401,351
6	JAZZ	Jazz Pharmaceuticals plc	1,204,353	$227,682,931
7	IONS	Ionis Pharmaceuticals Inc	2,363,567	$177,480,242
8	TERN	Terns Pharmaceuticals, Inc.	2,869,728	$151,292,056

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$2,730	3,000	0.0%	Shares	Defined	2026-05-13
2025-12-31	$3,390	3,000	+8723.5%	Shares	Defined	2026-02-11
2025-09-30	$48	34	+3.0%	Shares	Defined	2025-11-26
2025-06-30	$46	33	+26.9%	Shares	Defined	2025-08-12
2025-03-31	$30	26	-99.1%	Shares	Defined	2025-05-12
2024-06-30	$5,160	3,000	-0.9%	Shares	Defined	2024-12-26
2024-03-31	$3,511	3,027	+14314.3%	Shares	Defined	2024-12-26
2023-12-31	$21	21	+61.5%	Shares	Defined	2024-12-26
2023-09-30	$17	13	-99.7%	Shares	Defined	2023-11-14
2020-09-30	$14,668	3,820	—	Shares	Defined	2020-11-12
No filing history on record for this holder in this stock.